-
Effective clinical supervision in substance use disorder treatment programs and counselor job performance.
Laschober TC, de Tormes Eby LT, Sauer JB. Effective clinical supervision in substance use disorder treatment programs and counselor job performance. Journal of Mental Health Counseling 2013;35(1):76-94.
-
Quality of clinical supervision and counselor emotional exhaustion: The potential mediating roles of organizational and occupational commitment.
Knudsen HK, Roman PM, Abraham AJ. Quality of clinical supervision and counselor emotional exhaustion: The potential mediating roles of organizational and occupational commitment. Journal of Substance Abuse Treatment 2013;44(5):528-533.
-
Cocaine Use Reduction with Buprenorphine (CURB): Rationale, design, and methodology.
Mooney LJ, Nielsen S, Saxon AJ, Hillhouse M, Thomas C, Hasson A, Stablein D, McCormack J, Lindblad R, Ling W. Cocaine Use Reduction with Buprenorphine (CURB): Rationale, design, and methodology. Contemporary Clinical Trials 2013;34(2):196-204.
-
A comparison of buprenorphine taper outcomes between prescription opioid and heroin users.
Nielsen S, Hillhouse M, Thomas C, Hasson A, Ling W. A comparison of buprenorphine taper outcomes between prescription opioid and heroin users. Journal of Addiction Medicine 2013;7(1):33-38.
-
Risk of methylphenidate-induced prehypertension in normotensive adult smokers with attention deficit hyperactivity disorder.
Westover AN, Nakonezny PA, Winhusen TJ, Adinoff BH, Vongpatanasin W. Risk of methylphenidate-induced prehypertension in normotensive adult smokers with attention deficit hyperactivity disorder. Journal of Clinical Hypertension 2013;15(2):124-132.
-
Racial/ethnic differences in the rates and correlates of HIV risk behaviors among drug abusers.
Brooks AJ, Lokhnygina Y, Meade CS, Potter JS, Calsyn DA, Greenfield SF. Racial/ethnic differences in the rates and correlates of HIV risk behaviors among drug abusers. American Journal on Addictions 2013;22(1):136-147.
-
Buprenorphine/naloxone and methadone effects on laboratory indices of liver health: A randomized trial.
Saxon AJ, Ling W, Hillhouse M, Thomas C, Hasson A, Ang A, Doraimani G, Tasissa G, Lokhnygina Y, Leimberger JD, Bruce RD, McCarthy J, Wiest K, McLaughlin P, Bilangi R, Cohen AJ, Woody GE, Jacobs P. Buprenorphine/naloxone and methadone effects on laboratory indices of liver health: A randomized trial. Drug and Alcohol Dependence 2013;128(1-2):71-76.
-
Preliminary evidence that adherence to counseling mediates the effects of pretreatment self-efficacy and motivation on outcome of a cessation attempt in smokers with ADHD.
Heffner JL, Lewis DF, Winhusen TJ. Preliminary evidence that adherence to counseling mediates the effects of pretreatment self-efficacy and motivation on outcome of a cessation attempt in smokers with ADHD. Nicotine & Tobacco Research 2013;15(2):393-400.
-
The cost-effectiveness of rapid HIV testing in substance abuse treatment: Results of a randomized trial.
Schackman BR, Metsch LR, Colfax GN, Leff JA, Wong A, Scott CA, Feaster DJ, Gooden LK, Matheson T, Haynes LF, Paltiel AD, Walensky RP. The cost-effectiveness of rapid HIV testing in substance abuse treatment: Results of a randomized trial. Drug and Alcohol Dependence 2013;128(1-2):90-97.
-
Possible barriers to enrollment in substance abuse treatment among a diverse sample of Asian Americans and Pacific Islanders: Opinions of treatment clients.
Masson CL, Shopshire MS, Sen S, Hoffman KA, Hengl NS, Bartolome J, McCarty D, Sorensen JL, Iguchi MY. Possible barriers to enrollment in substance abuse treatment among a diverse sample of Asian Americans and Pacific Islanders: Opinions of treatment clients. Journal of Substance Abuse Treatment 2013;44(3):309-315.